QQQ   438.87 (+0.83%)
AAPL   181.66 (+0.13%)
MSFT   409.91 (+0.54%)
META   490.01 (+1.24%)
GOOGL   138.75 (+1.74%)
AMZN   175.07 (+1.10%)
TSLA   202.90 (+0.43%)
NVDA   795.35 (+2.41%)
NIO   5.73 (+5.52%)
AMD   182.73 (+3.51%)
BABA   74.68 (+0.12%)
T   17.04 (+0.47%)
F   12.38 (+0.65%)
MU   89.33 (-0.42%)
CGC   3.39 (+0.89%)
GE   155.94 (+0.21%)
DIS   111.98 (+1.06%)
AMC   4.66 (-6.61%)
PFE   27.00 (-0.15%)
PYPL   61.66 (+2.34%)
XOM   104.77 (+0.43%)
QQQ   438.87 (+0.83%)
AAPL   181.66 (+0.13%)
MSFT   409.91 (+0.54%)
META   490.01 (+1.24%)
GOOGL   138.75 (+1.74%)
AMZN   175.07 (+1.10%)
TSLA   202.90 (+0.43%)
NVDA   795.35 (+2.41%)
NIO   5.73 (+5.52%)
AMD   182.73 (+3.51%)
BABA   74.68 (+0.12%)
T   17.04 (+0.47%)
F   12.38 (+0.65%)
MU   89.33 (-0.42%)
CGC   3.39 (+0.89%)
GE   155.94 (+0.21%)
DIS   111.98 (+1.06%)
AMC   4.66 (-6.61%)
PFE   27.00 (-0.15%)
PYPL   61.66 (+2.34%)
XOM   104.77 (+0.43%)
QQQ   438.87 (+0.83%)
AAPL   181.66 (+0.13%)
MSFT   409.91 (+0.54%)
META   490.01 (+1.24%)
GOOGL   138.75 (+1.74%)
AMZN   175.07 (+1.10%)
TSLA   202.90 (+0.43%)
NVDA   795.35 (+2.41%)
NIO   5.73 (+5.52%)
AMD   182.73 (+3.51%)
BABA   74.68 (+0.12%)
T   17.04 (+0.47%)
F   12.38 (+0.65%)
MU   89.33 (-0.42%)
CGC   3.39 (+0.89%)
GE   155.94 (+0.21%)
DIS   111.98 (+1.06%)
AMC   4.66 (-6.61%)
PFE   27.00 (-0.15%)
PYPL   61.66 (+2.34%)
XOM   104.77 (+0.43%)
QQQ   438.87 (+0.83%)
AAPL   181.66 (+0.13%)
MSFT   409.91 (+0.54%)
META   490.01 (+1.24%)
GOOGL   138.75 (+1.74%)
AMZN   175.07 (+1.10%)
TSLA   202.90 (+0.43%)
NVDA   795.35 (+2.41%)
NIO   5.73 (+5.52%)
AMD   182.73 (+3.51%)
BABA   74.68 (+0.12%)
T   17.04 (+0.47%)
F   12.38 (+0.65%)
MU   89.33 (-0.42%)
CGC   3.39 (+0.89%)
GE   155.94 (+0.21%)
DIS   111.98 (+1.06%)
AMC   4.66 (-6.61%)
PFE   27.00 (-0.15%)
PYPL   61.66 (+2.34%)
XOM   104.77 (+0.43%)
NASDAQ:RDNT

RadNet (RDNT) Stock Price, News & Analysis

$37.67
+0.14 (+0.37%)
(As of 10:03 AM ET)
Today's Range
$37.14
$38.31
50-Day Range
$33.57
$38.95
52-Week Range
$22.70
$39.55
Volume
31,960 shs
Average Volume
347,773 shs
Market Capitalization
$2.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$34.00

RadNet MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9.4% Downside
$34.00 Price Target
Short Interest
Healthy
3.75% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
1.18mentions of RadNet in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$354,227 Sold Last Quarter
Proj. Earnings Growth
-14.29%
From $0.42 to $0.36 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.25 out of 5 stars

Medical Sector

353rd out of 958 stocks

Medical Laboratories Industry

12th out of 20 stocks


RDNT stock logo

About RadNet Stock (NASDAQ:RDNT)

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Stock Price History

RDNT Stock News Headlines

Here's what to expect from RadNet's earnings report
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
RadNet (RDNT) Set to Announce Earnings on Friday
Radnet Inc.
RDNT Sep 2024 30.000 put
Rare Earth Elements: The Workhorse of The Tech Revolution
They're the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are.
RDNT Jun 2024 30.000 put
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
2/28/2024
Next Earnings (Confirmed)
3/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:RDNT
Employees
9,067
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$34.00
High Stock Price Target
$42.00
Low Stock Price Target
$30.00
Potential Upside/Downside
-9.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$10.65 million
Pretax Margin
2.49%

Debt

Sales & Book Value

Annual Sales
$1.43 billion
Cash Flow
$3.43 per share
Book Value
$8.57 per share

Miscellaneous

Free Float
65,939,000
Market Cap
$2.59 billion
Optionable
Optionable
Beta
1.67

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Howard G. Berger M.D. (Age 78)
    Chairman, President & CEO
    Comp: $5.56M
  • Mr. Mark D. Stolper (Age 53)
    Executive VP & CFO
    Comp: $1.13M
  • Mr. Mital Patel (Age 38)
    Executive VP of Financial Planning & Analysis and Chief Administrative Officer
    Comp: $1.15M
  • Mr. Norman R. HamesMr. Norman R. Hames (Age 68)
    President & COO of Western Operations
    Comp: $1.28M
  • Mr. Stephen M. Forthuber (Age 63)
    President & COO of Eastern Operations
    Comp: $1.3M
  • Ms. Christine Nayoma Gordon (Age 61)
    Senior VP of Operations - Northern California & Director
    Comp: $384.38k
  • Mr. Ranjan Jayanathan (Age 68)
    Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Dr. Gregory Sorensen M.D. (Age 62)
    Executive VP, Chief Science Officer & Director
  • Ms. Laura Foster BSRT
    MPH, J.D., Senior Vice President of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz (Age 59)
    Executive VP, Chief Legal Officer & Corporate Secretary














RDNT Stock Analysis - Frequently Asked Questions

Should I buy or sell RadNet stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings
or view top-rated stocks.

What is RadNet's stock price target for 2024?

3 Wall Street research analysts have issued 1-year target prices for RadNet's stock. Their RDNT share price targets range from $30.00 to $42.00. On average, they predict the company's stock price to reach $34.00 in the next twelve months. This suggests that the stock has a possible downside of 9.4%.
View analysts price targets for RDNT
or view top-rated stocks among Wall Street analysts.

How have RDNT shares performed in 2024?

RadNet's stock was trading at $34.77 on January 1st, 2024. Since then, RDNT shares have increased by 7.9% and is now trading at $37.53.
View the best growth stocks for 2024 here
.

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 1st 2024.
View our RDNT earnings forecast
.

How can I listen to RadNet's earnings call?

RadNet will be holding an earnings conference call on Friday, March 1st at 10:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "10186577".

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) announced its quarterly earnings results on Wednesday, November, 8th. The medical research company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.08. The medical research company had revenue of $401.97 million for the quarter, compared to analysts' expectations of $391.63 million. RadNet had a net margin of 0.25% and a trailing twelve-month return on equity of 4.16%. RadNet's revenue was up 14.8% on a year-over-year basis. During the same period last year, the firm earned $0.09 earnings per share.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

Who are RadNet's major shareholders?

RadNet's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (6.17%), Dimensional Fund Advisors LP (2.53%), Edmond DE Rothschild Holding S.A. (2.24%), Principal Financial Group Inc. (1.87%), Point72 Asset Management L.P. (1.29%) and Global Alpha Capital Management Ltd. (1.27%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson.
View institutional ownership trends
.

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RDNT) was last updated on 2/29/2024 by MarketBeat.com Staff